Correlation Between National Beverage and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both National Beverage and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National Beverage and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National Beverage Corp and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on National Beverage and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National Beverage with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of National Beverage and Artiva Biotherapeutics,.
Diversification Opportunities for National Beverage and Artiva Biotherapeutics,
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between National and Artiva is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding National Beverage Corp and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and National Beverage is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National Beverage Corp are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of National Beverage i.e., National Beverage and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between National Beverage and Artiva Biotherapeutics,
Given the investment horizon of 90 days National Beverage Corp is expected to generate 0.21 times more return on investment than Artiva Biotherapeutics,. However, National Beverage Corp is 4.73 times less risky than Artiva Biotherapeutics,. It trades about -0.41 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about -0.1 per unit of risk. If you would invest 4,669 in National Beverage Corp on October 14, 2024 and sell it today you would lose (391.00) from holding National Beverage Corp or give up 8.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
National Beverage Corp vs. Artiva Biotherapeutics, Common
Performance |
Timeline |
National Beverage Corp |
Artiva Biotherapeutics, |
National Beverage and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with National Beverage and Artiva Biotherapeutics,
The main advantage of trading using opposite National Beverage and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National Beverage position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.National Beverage vs. Celsius Holdings | National Beverage vs. Monster Beverage Corp | National Beverage vs. Coca Cola Femsa SAB | National Beverage vs. Keurig Dr Pepper |
Artiva Biotherapeutics, vs. Oatly Group AB | Artiva Biotherapeutics, vs. National Beverage Corp | Artiva Biotherapeutics, vs. SNDL Inc | Artiva Biotherapeutics, vs. Keurig Dr Pepper |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Transaction History View history of all your transactions and understand their impact on performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |